3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
5
Breast
5
Gastrointestinal
4
Tumor-Agnostic
3
Thoracic
3
Sarcoma
2
Dermatologic
2
Gynecologic
1
CNS
1
Conditions
Ovarian Neoplasms
29
Uterine Cervical Neoplasms
23
Endometrial Neoplasms
14
Breast Neoplasms
10
Neoplasms
8
Uterine Cervical Dysplasia
5
Carcinoma, Ovarian Epithelial
5
Peritoneal Neoplasms
4
Papillomavirus Infections
4
Lung Neoplasms
4
Fallopian Tube Neoplasms
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Pancreatic Neoplasms
3
Neoplastic Cells, Circulating
3
Hereditary Breast and Ovarian Cancer Syndrome
3
Disease
3
Uterine Neoplasms
2
Prostatic Neoplasms
2
Primary Ovarian Insufficiency
2
Ovarian Diseases
2
Melanoma
2
Leukemia
2
Kidney Neoplasms
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Endometrial Hyperplasia
2
Vulvar Neoplasms
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Interventions
pembrolizumab
23
Paclitaxel
14
Cyclophosphamide
13
Carboplatin
12
Specimen Handling
10
Magnetic Resonance Spectroscopy
10
Biopsy
9
fludarabine
8
Nivolumab
7
Leucovorin
7
Gemcitabine
7
Fluorouracil
7
Doxorubicin
7
aldesleukin
6
Oxaliplatin
6
Cisplatin
6
liposomal doxorubicin
5
Topotecan
5
Taxes
5
Irinotecan
5
Interleukin-2
5
olaparib
4
atezolizumab
4
Hyperthermic Intraperitoneal Chemotherapy
4
Drug Therapy
4
seribantumab
3
fludarabine phosphate
3
durvalumab
3
dostarlimab
3
dehydroftorafur
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Blood Specimen Collection
×
Gynecologic
×
Clear all
NCT06349642
2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
324 enrolled